All AbMole products are for research use only, cannot be used for human consumption.
For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.
Ibalizumab (TMB-355) is a humanised IgG4 monoclonal antibody that prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research.
| CAS Number | 680188-33-4 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
[1] Hannah A Blair. Drugs. Ibalizumab: A Review in Multidrυg-Resistant HIV-1 Infection
[2] No authors listed. Ibalizumab
[3] No authors listed. Ibalizumab
[4] Robert L Bettiker, et al. Curr Opin HIV AIDS. Ibalizumab
[5] Anthony Markham. Drugs. Ibalizumab: First Global Approval
| Related HIV Protease Products |
|---|
| Atazanavir Sulfate
Atazanavir sulfate (BMS-232632, Reyataz) is an azapeptide inhibitor of HIV-1 protease. Atazanavir sulfate is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp). Atazanavir sulfate is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. |
| Bevirimat
Bevirimat (BVM), also known as PA-457 or MPC-4326, is a novel Human Immunodeficiency Virus type 1 (HIV-1) maturation inhibitor. |
| Lopinavir
Lopinavir (ABT-378) is a potent protease inhibitor. |
| Ritonavir
Ritonavir is an HIV protease inhibitor used in the study of HIV infection and AIDS. Ritonavir (ABT 538) |
| Delavirdine mesylate
Delavirdine mesylate is a nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
